(Downloading may take up to 30 seconds. If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.
Figure 2
Effects of dietary agents on the extrinsic and intrinsic pathways of apoptosis in prostate cancer. The extrinsic pathway is
triggered by death receptors and involves activation of the initiator caspase-8, which directly activates caspase-3 causing
apoptosis. The intrinsic pathway is activated by different apoptotic stimuli that lead to release of cytochrome c from mitochondria and activation of caspase-9. This step can be inhibited by the anti-apoptotic members of the Bcl-2 family
of apoptosis regulators. Cytochrome c interacts with APAF-1 and caspase-9 to promote the activation of caspase-3. Most dietary agents interfere with the key regulators
of the apoptotic pathway.
2007Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate
cancer cells both in vitro and in vivo.
Clinical Cancer Research
131611–
1619.
1997Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells.
Journal of the National Cancer Institute
891881–
1886.
2004Pomegranate extracts potently suppress proliferation, xenograft growth, and invasion of human prostate cancer cells.
Journal of Medicinal Food
7274–
283.
2000Dietary intakes of flavonols, flavones and isoflavones by Japanese women and the inverse correlation between quercetin intake
and plasma LDL cholesterol concentration.
Journal of Nutrition
1302243–
2250.
2000Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies
in humans and in atherosclerotic apolipoprotein E-deficient mice.
American Journal of Clinical Nutrition
711062–
1076.
2006Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells is mediated via modulation of phosphatidylinositol 3′-kinase/Akt
pathway and Bcl-2 family proteins.
Molecular Cancer Therapeutics
51335–
1341.
2004A concentrated aglycone isoflavone preparation (GCP) that demonstrates potent anti-prostate cancer activity in vitro and in vivo.
Clinical Cancer Research
105282–
5292.
2006Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate
intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study.
Cancer Research
661234–
1240.
2003Epigallocatechin-3-gallate is a potent natural inhibitor of fatty acid synthase in intact cells and selectively induces apoptosis
in prostate cancer cells.
International Journal of Cancer
106856–
862.
2004The chemopreventive action of catechins in the TRAMP mouse model of prostate carcinogenesis is accompanied by clusterin over-expression.
Carcinogenesis
252217–
2224.
2005A prospective clinical trial of green tea for hormone refractory prostate cancer: an evaluation of the complementary/alternative
therapy approach.
Urologic Oncology
23108–
113.
2005Chemosensitization of hormone-refractory prostate cancer cells by curcumin to TRAIL-induced apoptosis.
Journal of Experimental Therapeutics and Oncology
581–
91.
2007Curcumin [1,7-bis(4-hydroxy-3-methoxyphenyl)-1-6-heptadine-3,5-dione; C21H20O6] sensitizes human prostate cancer cells to
tumor necrosis factor-related apoptosis-inducing ligand/Apo2L-induced apoptosis by suppressing nuclear factor-kappaB via inhibition
of the prosurvival Akt signaling pathway.
Journal of Pharmacology and Experimental Therapeutics
321616–
625.
2001Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits
angiogenesis of LNCaP prostate cancer cells in vivo.
Prostate
47293–
303.
2004Sensitization for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by the chemopreventive agent resveratrol.
Cancer Research
64337–
346.
2000Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing.
Journal of Agricultural and Food Chemistry
484581–
4589.
2000Growth inhibition, cell-cycle dysregulation, and induction of apoptosis by green tea constituent (−)-epigallocatechin-3-gallate
in androgen-sensitive and androgen-insensitive human prostate carcinoma cells.
Toxicology and Applied Pharmacology
16482–
90.
2005Physiologically attainable concentrations of lycopene induce mitochondrial apoptosis in LNCaP human prostate cancer cells.
Experimental Biology and Medicine
230171–
179.
2005Ablation of either p21 or Bax prevents p53-dependent apoptosis induced by green tea polyphenol epigallocatechin-3-gallate.
FASEB Journal
19789–
791.
2007Lycopene differentially induces quiescence and apoptosis in androgen-responsive and -independent prostate cancer cell lines.
Clinical Nutrition
26252–
263.
2002Induction of apoptosis in low to moderate-grade human prostate carcinoma by red clover-derived dietary isoflavones.
Cancer Epidemiology, Biomarkers and Prevention
111689–
1696.
2003Inhibition of the proteasome activity, a novel mechanism associated with the tumor cell apoptosis-inducing ability of genistein.
Biochemical Pharmacology
66965–
976.
2006Combined inhibitory effects of curcumin and phenethyl isothiocyanate on the growth of human PC-3 prostate xenografts in immunodeficient
mice.
Cancer Research
66613–
621.
2006Inhibition of EGFR signaling in human prostate cancer PC-3 cells by combination treatment with beta-phenylethyl isothiocyanate
and curcumin.
Carcinogenesis
27475–
482.
2004Potential mechanism of phytochemical-induced apoptosis in human prostate adenocarcinoma cells: therapeutic synergy in genistein
and beta-lapachone combination treatment.
Cancer Cell International
45.
2005Genistein, a dietary isoflavone, down-regulates the MDM2 oncogene at both transcriptional and posttranslational levels.
Cancer Research
658200–
8208.
2009Tea polyphenols decrease serum levels of prostate-specific antigen, hepatocyte growth factor, and vascular endothelial growth
factor in prostate cancer patients and inhibit production of hepatocyte growth factor and vascular endothelial growth factor
in vitro.
Cancer Prevention Research
2673–
682.
1998Effects of soybean isoflavones on cell growth and apoptosis of the human prostatic cancer cell line LNCaP.
Japanese Journal of Clinical Oncology
28360–
363.
2006Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate
cancer.
Clinical Cancer Research
124018–
4026.
2008aRegulation of signaling pathways involved in lupeol induced inhibition of proliferation and induction of apoptosis in human
prostate cancer cells.
Molecular Carcinogenesis
47916–
924.
2006Genistein inhibits radiation-induced activation of NF-kappaB in prostate cancer cells promoting apoptosis and G2/M cell cycle arrest.
BMC Cancer
6107.
2008Pomegranate extract inhibits androgen-independent prostate cancer growth through a nuclear factor-kappaB-dependent mechanism.
Molecular Cancer Therapeutics
72662–
2671.
Growth factor signalling in prostatic growth: significance in tumour development and therapeutic targeting
British Journal of Pharmacology
147Suppl 22006S144–
S152.
2005A novel dietary triterpene Lupeol induces fas-mediated apoptotic death of androgen-sensitive prostate cancer cells and inhibits
tumor growth in a xenograft model.
Cancer Research
6511203–
11213.
2008Suppression of prostate cancer growth by resveratrol in the transgenic rat for adenocarcinoma of prostate (TRAP) model.
Asian Pacific Journal of Cancer Prevention
97–
14.
2007aCurcumin enhances the apoptosis-inducing potential of TRAIL in prostate cancer cells: molecular mechanisms of apoptosis, migration
and angiogenesis.
Journal of Molecular Signaling
210.
2007bSensitization of TRAIL-resistant LNCaP cells by resveratrol (3,4′,5 tri-hydroxystilbene): molecular mechanisms and therapeutic
potential.
Journal of Molecular Signaling
27.
2008aGreen tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically
inhibits biomarkers associated with angiogenesis and metastasis.
Oncogene
272055–
2063.
2008bSuppression of NFkappaB and its regulated gene products by oral administration of green tea polyphenols in an autochthonous
mouse prostate cancer model.
Pharmaceutical Research
252135–
2142.
2002Genistein, a soy isoflavone, induces glutathione peroxidase in the human prostate cancer cell lines LNCaP and PC-3.
International Journal of Cancer
99846–
852.
2005Lycopene inhibits the growth of human androgen-independent prostate cancer cells in vitro and in BALB/c nude mice.
Journal of Nutrition
135287–
290.
2007GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and -independent mechanisms.
Prostate
67521–
535.
2009A combination of micronutrients is beneficial in reducing the incidence of prostate cancer and increasing survival in the
Lady transgenic model.
Cancer Prevention Research
2473–
483.
2003Tomato and soy polyphenols reduce insulin-like growth factor-I-stimulated rat prostate cancer cell proliferation and apoptotic
resistance in vitro via inhibition of intracellular signaling pathways involving tyrosine kinase.
Journal of Nutrition
1332367–
2376.
2009Genistein synergizes with RNA interference inhibiting survivin for inducing DU-145 of prostate cancer cells to apoptosis.
Cancer Letters
284189–
197.